• Kyodo

  • SHARE

Japan is considering using Avigan, an anti-influenza medication developed by a unit of Fujifilm Holdings Corp., to treat patients of the novel coronavirus, health minister Katsunobu Kato said Saturday.

“We will do everything we can,” Kato said on a TV program, noting that there is no established treatment for COVID-19 yet. The drug is also known as Favipiravir.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW